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Human umbilical cord mesenchymal stem cells (hUCMSCs) and human adipose tissue mesenchymal stem cells (hATMSCs) have the poten-
tial to differentiate into cardiomyocytes, making them promising therapeutic candidates for treating damaged cardiac tissues. Currently, how-
ever, the differentiated cells induced from hUCMSCs or hATMSCs can hardly display functional characteristics similar to cardiomyocytes. In
this study, we have investigated the effects of bioactive lipid sphingosine-1-phosphate (S1P) on cardiac differentiations of hUCMSCs and
hATMSCs in condition medium composed of cardiac myocytes culture medium or 5-azacytidine. Cardiac differentiations were identiﬁed
through immunoﬂuorescence staining, and the results were observed with ﬂuorescence microscopy and confocal microscopy. Synergistic ef-
fects of S1P and condition medium on cell viability were evaluated by MTT assays. Functional characteristics similar to cardiomyocytes were
evaluated through detecting calcium transient. The differentiated hUCMSCs or hATMSCs in each group into cardiomyocytes showed pos-
itive expressions of cardiac speciﬁc proteins, including α-actin, connexin-43 and myosin heavy chain-6 (MYH-6). MTT assays showed that
suitable differentiation time was 14 days and that the optimal concentration of S1P was 0.5μM. Moreover, incorporation of S1P and cardiac
myocytes culture medium gave rise to calcium transients, an important marker for displaying in vivo electrophysiological properties. This
feature was not observed in the S1P-5-azacytidine group, indicating the possible lack of cellular stimuli such as transforming growth
factor-beta, TGF-β. © 2016 The Authors. Cell Biochemistry and Function published by John Wiley & Sons, Ltd.
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INTRODUCTION
Mesenchymal stem cells (MSCs) have the ability to differenti-
ate into various types of tissue cells. This property is of
enormous potential to clinical applications in tissue
regeneration covering bone, cartilage, muscle and adipose.1–3
A number of recent reports have shown that MSCs could also
differentiate into cardiomyocytes in vivo and in vitro.4,5
Two types of MSCs, human umbilical cord mesenchymal
stem cells (hUCMSCs) and human adipose tissuemesenchymal
stem cells (hATMSCs), have been conﬁrmed to possess the
characteristics similar to MSCs from other sources. Therefore,
hUCMSCs or hATMSCs have the potential to differentiate into
cardiomyocytes and express cardiac spe- ciﬁc proteins, such
as sarcomeric α-actinin, cardiac troponin I, β-myosin heavy
chain and connexin-43.6–10 On the basis of these ﬁndings,
hUCMSCs or hATMSCs have become promising therapeutic
candidates for treating damaged cardiac tissues.8,11,12
However, the present differentiated cells from hUCMSCs or
hATMSCs that are induced simply from cardiac myocytes
culture medium (CMCM) or 5-azacytidine hardly display
functional characteristics similar to cardiomyocytes, such as
contractile activity or calcium transient. On the other hand,
microenvironmental factors such as mechanical cues, soluble
bioactive factors and electricity stimulation cannot only
regulate MSC differentiations but also modulate MSC
signalling to the surrounding environment.13 Therefore, it is
important to ﬁnd a bioactive factor combining with cardiac
differentiation medium for hUCMSCs or hATMSCs to
improve their functional cardiomyogenic differentiation.
Sphingosine-1-phosphate (S1P) is a pleiotropic bioactive
lipid capable of regulating diverse biological processes,
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including cell growth, cell survival, cell migration and
cell differentiation.14–16 A recent study has reported that
S1P dose-dependently stimulated the differentiation of
hATMSCs towards smooth muscle cells.13 A previous work
has also shown that S1P can promote the differentiation of
hUCMSCs towards functional cardiomyocytes under
CMCM.17 These studies have provided us clues of possible
induction of hUCMSCs under S1P into cardiomyocytes.
Furthermore, it is useful to ﬁnd out whether S1P can pro-
mote MSCs derived from other tissues such as hATMSCs
to differentiate towards functional cardiomyocytes under
CMCM and 5-azacytidine medium, also a popular induction
medium.
Therefore, in this study we have examined the induction
of both hUCMSCs and hATMSCs with S1P and 5-
azacytidine to investigate their effects on the
cardiomyogenic differentiation of the two MSCs in vitro.
In addition, we explored the induction time and the optimal
concentration of S1P by evaluating cell viability during the
induction processes.
MATERIALS AND METHODS
Cell culture and harvest
Human cardiac myocytes (HCM, Cat. No. 6200) and
hUCMSCs (Cat. No. 6252) were purchased from ScienCell
Research Laboratories (San Diego, CA, USA). Human adi-
pose tissue was obtained from ﬁve healthy female donor pa-
tients aged 18 to 45 undergoing elective liposuction with
informed patient consents. The hATMSCs were isolated as
reported previously.18 Brieﬂy, lipoaspirates were digested
using digestion buffer which was comprised of 0.1% colla-
genase type I and 0.25% trypsin (Sigma, v/v 1:1) and incu-
bated at 37 °C with constant agitation for 20min. Following
digestion, Dulbecco’s Modiﬁed Eagle Medium (DMEM,
Sigma) containing 10% fetal bovine serum (FBS, Sigma)
was added to inactivate the digestion buffer and the mixture
was centrifuged at 1500 rpm for 10min. The cellular pellet
was resuspended in culture medium (DMEM+10% FBS)
and plated in T ﬂasks.
For cultivation, the cells were kept in DMEM containing
10% FBS, 2mM glutamine (Sigma, USA), 100 units/ml
penicillin (Sigma, USA) and 100μgml1 streptomycin
(Sigma, USA) and were incubated at 37 °C under a humidi-
ﬁed atmosphere containing 5% CO2. Once the culture
reached over 90% conﬂuence, the cells were detached with
trypsin/EDTA (Sigma, USA) and collected by centrifuging
at 1000 rpm for 5min. The cells were plated into ﬂasks or
dishes at 5000 cells cm2 for subculturing. Cultures after
passage 4 (P4) were used in this study.
Cardiac myocyte culture medium collection
To collect the CMCM, HCM cells were seeded into the
ﬂasks at 5000 cells cm2. After 24 h of seeding, the culture
medium was collected and new culture medium was re-
placed every day.
Cardiomyogenic
hUCMSC or hATMSC differentiations into cardiomyocytes
were induced using a combination of chemicals (5-
azacytidine and S1P, both from Sigma) and cardiac micro-
environment (CMCM). The induction experiments were
divided into six groups: MSCs cultured in CMCM (group
A), in CMCM+0.1μM S1P (group B), in CMCM
+0.5μM S1P (group C), in CMCM+1.0μM S1P (group
D), in DMEM+5-azacytidine (group E), in DMEM+5-
azacytidine + 0.5μM S1P (group F) and two control
groups (hUCMSCs or hATMSCs cultured in DMEM as
negative control, HCM cultured in DMEM as positive
control). hATMSCs and hUCMSCs after P4 were seeded
into 24-well plates at 5000 cells cm2 and induced to dif-
ferentiate into cardiomyocytes after 3 days of plating with
the above media.
In 5-azacytidine groups (group E and group F), 10μM of
5-azacytidine was used. After incubating for 24 h in DMEM,
the cells were washed with phosphate buffer solution (PBS,
Sigma), and the media were changed to differentiation me-
dia. Then the media was changed every 3 days. Cell differ-
entiation was evaluated at the 7th day, the 14th day and
the 28th day after the drug treatment by immunoﬂuores-
cence staining of cardiac speciﬁc proteins.
In CMCM groups (groups A–D), the induction media
(CMCM with different concentrations of S1P at 0, 0.1, 0.5
and 1μM) were used. Each medium was changed every
3 days. Cell differentiations were evaluated at the 7th, 14th
and 28th day after the drug treatment by immunoﬂuores-
cence staining of cardiac speciﬁc proteins.
Immunoﬂuorescence staining of speciﬁc proteins
To identify whether hATMSCs and hUCMSCs induced in
5-azacytidine groups and CMCM groups became differen-
tiated into cardiomyocytes, immunoﬂuorescence staining
of three cardiomyocyte proteins was performed: α-actin,
connexin-43 and MYH-6 (myosin heavy chain-6). Firstly,
the cells were cultured and induced on glass cover slips.
After induction, the cells were washed three times with
PBS and ﬁxed with 4% paraformaldehyde at the room tem-
perature for 15min. After being washed three times again
with PBS, the ﬁxed cells were permeabilized for 30min
in PBS containing 0.1% Triton X-100, and then blocked
with 10% normal goat serum in PBS for an hour at 37 °
C. Then the cells were incubated in rabbit polyclonal
primary antibodies against α-actin, connexin-43 and
MYH-6, respectively, at 4 °C overnight. The cells were
subsequently incubated in FITC-conjugated secondary an-
tibodies at the room temperature for 1 h. Negative controls
and positive controls were also performed to offset the dis-
turbance of the primary or secondary antibodies. The cells
on the glass cover slips were counterstained with DAPI
(Sigma) to visualize their nuclei. The results were ob-
served with ﬂuorescence microscopy and confocal micros-
copy, and the images were analysed using software of
Image J.
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Cell activity assay
To compare the cell activities under different induction con-
ditions, hATMSCs and hUCMSCs were seeded in 6-well
plates in growth medium (DMEM+10% FBS) ﬁrst. After
3 days of culture, the growth medium was changed into in-
duction medium containing different concentration of S1P.
The cell activities in different induction groups were mea-
sured using MTT assays at 7th day and 14th day, respec-
tively. Three hundred microlitres of MTT solution
(5mgml1 in PBS) was added into each well of 6-well plate
and incubated at 37 °C for 4 h. Then, the MTT solution was
aspirated from the wells, and 3ml of dimethyl sulfoxide
(DMSO) was added to solubilize the formazan crystals. Af-
ter incubation of 10min, 200μL of DMSO solution was
then transferred to new wells of 96-well plate to facilitate
the absorbance measurement at 570 nm. All measurements
were performed in triplicate.
Electrophysiological measurement
To compare the electrophysiological features of the cells un-
der different induction conditions, hATMSCs and
hUCMSCs were seeded in 6-well plates in growth medium
(DMEM+10% FBS) ﬁrst. After 3 days of culture, the
growth medium was changed into induction medium
including group A (CMCM), group C (CMCM+0.5μM
S1P), group E (5-azacytidine) and group F (5-azacytidine
+ 0.5μM S1P). The electrophysiological features of the cells
in different induction groups were measured using the patch
clamp technique at the 14th day.
For electrophysiological recordings, the cells were plated
on the 9mm diameter round cover slips in dishes containing
DMEM and left for one day before the experiments. For
electrical ﬁeld stimulation, the cover slips were placed in
the middle of a chamber under microscope and perfused
with 37 °C pre-warmed DMEM for 5min. Then 5μL of
the Fluo-3 calcium indicator (Invitrogen) was added into
the chamber with both in-ﬂow and out-ﬂow being shut. Af-
ter incubation of 10min, the cells were continuously per-
fused with 37 °C pre-warmed DMEM for at least 40min to
allow the de-esteriﬁcation. The cells were then exposed un-
der ﬂuorescence at 488 nm, the excitation wavelength of
Fluo-3. Any calcium transient induced by the stimulation
would be observed by 40× oil immersion objective and re-
corded by pCLAMP programme 10.0 (Axon Instrument
Inc, 1101 Chess Drive, Foster City, CA, USA). The stimula-
tion was performed by applying rectangular pulses of alter-
nate polarity with 2ms duration and 200mA amplitude.
For electrophysiological recordings, the cells were stimu-
lated with constant pulses at 1Hz frequency by Spike 2 pro-
gramme. Electrical signals were digitized at 5 kHz by a
DigiData 1322A A/D converter (Axon Instruments Inc)
and stored on a computer for later analysis.
Statistical analysis
All the experiments were repeated three times, and the data
were averaged from three separate experiments. The data
were analysed by OriginPro8.0 software (OriginLab Corpo-
ration, USA) and expressed as mean ± standard deviation
(SD, n=3). The Student’s t-tests were used to compare dif-
ferences between the two groups in differentiations of
hATMSCs and hUCMSCs into cardiomyocytes and cell vi-
ability, with p< 0.05 being considered signiﬁcant.
RESULTS
Inﬂuence of induction time on differentiation
To offset various disturbances including inﬂuences from the
primary or secondary antibodies, negative and positive con-
trols were performed. hUCMSCs or hATMSCs were cul-
tured in normal medium (DMEM) as negative controls,
while HCM cells were cultured in cardiomyogenic medium
(DMEM) as positive control. The results of the two negative
controls showed that hUCMSCs (Figure S1B) and
hATMSCs (Figure S1C) had no expression of the three car-
diac speciﬁc proteins (α-actin, connexin-43 and MYH-6),
while HCM cells expressed all of them (Figure S1A).
Differentiations of hATMSCs and hUCMSCs in each
group into cardiomyocytes were then undertaken and evalu-
ated by immunoﬂuorescence staining of cardiac speciﬁc pro-
teins (α-actin, connexin-43 and MYH-6) on the 7th, 14th and
28th day, respectively. As a representative example, the re-
sults of groups C and D are shown in Figures 1 and 2, with
those of the control groups being presented in Figure S1. It
can be seen that both hUCMSCs (Figure 1) and hATMSCs (
Figure 2) expressed the three cardiac speciﬁc proteins after
7 days of induction under the inﬂuence of CMCM and S1P
(0.5 and 1μM) , but the ﬂuorescence intensities were weak
at this time. After 14days of incubation, most of the cells con-
tinued to express the three cardiac speciﬁc proteins and the
ﬂuorescence intensities became stronger than those at the
7th day. On the 28th day, the expressions of the three cardiac
speciﬁc proteins were similar to those obtained on the 14th
day in intensity, but most of the cells became dead and only
a small number of them were left, indicating stronger expres-
sions of the three proteins from the surviving cells. These re-
sults indicated that the suitable differentiation time was likely
to be around day 14 taking into account the balance between
protein expression and cell survival rate. Thus, the optimal in-
duction time was set at day 14 in the subsequent experiments.
Inﬂuence of S1P concentration on differentiation
The effects of S1P concentration on the cardiomyogenic dif-
ferentiation of the two sources of MSCs are shown in Figures
3 and 4. For hUCMSCs, their α-actin and connexin-43 expres-
sions increased with S1P concentration in CMCM groups
(Figure 3), and there were signiﬁcant increases compared with
group A (CMCM) (Figure 5A, B; p< 0.05). In 5-azacytidine
groups, the expressions of α-actin and connexin-43 in the
presence of S1P were stronger than those without S1P (Fig-
ure 3), but they were both lower than the culture conditions
in CMCM without any 5-azacytidine or S1P (Figure 5A, B),
showing some subtle inhibitive inﬂuence from 5-azacytidine
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Figure 1. Inﬂuence of induction time of S1P on the cardiogenic differentiation of hUCMSCs. The expressions of the three cardiac speciﬁc proteins were used
to evaluate the cardiomyogenic differentiations of hUCMSCs. The results of group C (CMCM+ 0.5 μM S1P) were presented. On the 7th day, the cells began to
express α-actin, connexin-43 and MYH-6, but the ﬂuorescence intensities were weak. At the 14th day, most of the cells expressed three speciﬁc proteins and the
ﬂuorescence intensities were stronger than those on the 7th day. The expressions of the cardiac speciﬁc proteins on the 28th day were similar to those on the
14th day, but then most of the cells were dead and only a small number of them remained alive. The bars are 100 μm
Figure 2. Inﬂuence of induction time of S1P on the cardiogenic differentiation of hATMSCs. The expressions of the three cardiac speciﬁc proteins were used
to evaluate the cardiomyogenic differentiations of hATMSCs. The results of group D (CMCM+ 1.0 μM S1P) were presented. On the 7th day, the cells began to
express α-actin, connexin-43 and MYH-6, but the ﬂuorescence intensities were weak. At the 14th day, most of the cells expressed three speciﬁc proteins and the
ﬂuorescence intensities were stronger than those on the 7th day. The expressions of cardiac speciﬁc proteins on the 28th day were similar to those on the 14th
day, but most of the cells were dead and only a small number of them remained alive. The bars are 100 μm
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Figure 3. Inﬂuence of S1P concentration on the differentiation of hUCMSCs toward cardiomyocytes in induction media. This experiment was divided into
six groups, including CMCM (group A), CMCM+ 0.1 μM S1P (group B), CMCM+ 0.5 μM S1P (group C), CMCM+ 1.0 μM S1P (gorup D), DMEM
+ 5-azacytidine (group E) and DMEM+ 5-azacytidine + 0.5 μM S1P (group F). The differentiations were examined by immunoﬂuorescence staining of cardiac
speciﬁc proteins, and the results were evaluated by confocal microscopy. All the differentiated cells in the six groups expressed three cardiac speciﬁc proteins
(α-actin, connexin-43 and MYH-6), but the ﬂuorescence intensities from these expressions were different. The bars are 20 μm
Figure 4. Inﬂuence of S1P concentration on the differentiation of hATMSCs toward cardiomyocytes in induction media. This experiment was divided into six
groups, including CMCM (group A), CMCM+ 0.1 μM S1P (group B), CMCM+ 0.5 μM S1P (group C), CMCM+ 1.0 μM S1P (gorup D), DMEM
+ 5-azacytidine (group E) and DMEM+ 5-azacytidine + 0.5 μM S1P (group F). The differentiations were examined by immunoﬂuorescence staining of cardiac
speciﬁc proteins, and the results were evaluated by confocal microscopy. All the differentiated cells in the six groups expressed three cardiac speciﬁc proteins
(α-actin, connexin-43 and MYH-6), but the ﬂuorescence intensities from these expressions were different. The bars are 20 μm
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to the function of S1P. Meanwhile, the expression of MYH-6
increased with the concentration of S1P and reached the peak
value in CMCM+0.5μM S1P group (Figure 3). Addition of
S1P thus made signiﬁcant differences compared with group
A as in the case of the other two proteins (Figure 5C;
p< 0.05). In contrast, addition of 5-azacytidine with and with-
out S1P in DMEM produced lower expressions of MYH-6
than those in group A, a trend similar to those observed with
the other two proteins, but there was no signiﬁcant difference
compared with group E (5-azacytidine) (Figure 5C; p< 0.05).
For hATMSCs, whether in CMCM groups or 5-
azacytidine groups, the expressions of the three cardiac spe-
ciﬁc proteins were all enhanced by S1P and increased with
its concentration (Figure 6), although the extent of increase
varied and was different from the respective case as observed
in hUCMSCs. In the CMCM groups, addition of 1μM S1P
led to substantial increases in α-actin and MYH-6. In the
5-azacytidine groups, the levels of expressions of all three
proteins were similar to their respective ones in group E
(5-azacytidine), but addition of 0.5μM S1P led to increased
expressions of conexion-43 and MYH-6 (Figure 6; p<0.05).
Inﬂuence of S1P concentration on cell activity
The inﬂuences of S1P concentrations on cell activities of
hUCMSCs and hATMSCs were assessed by MTT assays
and are shown in Figures 7 and 8. For the CMCM series
in groups A–D, cell activities decreased with time (as
assayed on the 7th and 14th days) and decreasing S1P con-
centration. There were signiﬁcant differences compared
with the control (group A) (p< 0.05). In 5-azacytidine
groups (groups E and F), however, the trends are opposite
as far as time and 5-azacytidine are concerned, i.e. cell activ-
ities increased with time and addition of 5-azacytidine, al-
though the results did show the same trend of decrease of
cell activity with addition of S1P (p<0.05). In the DMEM
systems (groups E and F) increase in cell viability with time
because of DMEM acting as a popular cell growth medium.
It was observed that cell activities cultured in DMEM were
higher than those cultured in CMCM. CMCM is not a pro-
liferation medium but a differentiation medium, hence
explaining why the viabilities of the cells cultured in
CMCM with or without S1P on the 14th day were lower
than those on the 7th day.
Figure 5. Fluorescence intensity analysis of the three cardiac speciﬁc proteins expressed in the six groups for hUCMSCs. Expressions of α-actin and
connexin-43 were enhanced with increasing S1P concentration whilst that of MYH-6 showed an initial increase with the concentration of S1P and then
declined, reaching the peak value in CMCM+ 0.5 μM S1P group. The ﬂuorescence intensities were analysed using the software Image J. The data were
expressed as mean ± SD (n = 3). Asterisk indicates statistically signiﬁcant (p< 0.05) difference of ﬂuorescence intensity compared with CMCM group or
5-azacytidine group
Figure 6. Fluorescence intensity analysis of the three cardiac speciﬁc proteins expressed in the six groups for hATMSCs. The expressions of the three cardiac
speciﬁc proteins were all enhanced with increasing S1P concentration, whether in CMCM groups or in 5-azacytidine groups. The ﬂuorescence intensity was
analysed using the software Image J. The data were expressed as mean ± SD (n = 3). Asterisk indicates statistically signiﬁcant (p< 0.05) difference of ﬂuores-
cence intensity compared with CMCM group or 5-azacytidine group
168 l. jiang et al.
© 2016 The Authors. Cell Biochemistry and Function published by John Wiley & Sons, Ltd. Cell Biochem Funct 2016; 34: 163–172.
Figure 7. Cell activity assays in different groups of hUCMSCs by MTT. The experiment was divided into seven groups, including CMCM (group A),
CMCM+ 0.1 μM S1P (group B), CMCM+ 0.5 μM S1P (group C), CMCM+ 1.0 μM S1P (group D), DMEM+ 5-azacytidine (group E), DMEM+ 5-
azacytidine + 0.5 μM S1P (group F) and DMEM (control group). Cell activities of hUCMSCs decreased with increasing S1P concentration according to the
results of groups A–D on both 7th and 14th days. In groups A–D, the cell viability on the 14th day was lower than that on the 7th day. In group E and group
F, S1P signiﬁcantly reduced the cell viability. In group A and control group, cell activity cultured in DMEM was higher than that cultured in CMCM. The data
were expressed as mean ± SD (n = 3). Aterisk indicates statistically signiﬁcant (p< 0.05) difference of cell activity compared with CMCM group. Number sign
indicates statistically signiﬁcant (p< 0.05) difference of cell activity compared with 5-azacytidine group
Figure 8. Cell activity assays in different groups of hATMSCs by MTT. The experiment was divided into seven groups, including CMCM (group A),
CMCM+ 0.1 μM S1P (group B), CMCM+ 0.5 μM S1P (group C), CMCM+ 1.0 μM S1P (group D), DMEM+ 5-azacytidine (group E), DMEM+ 5-
azacytidine + 0.5 μM S1P (group F) and DMEM (control group). Cell activity of hATMSCs decreased with increasing S1P concentration according to the
results of groups A–D on both 7th and 14th days. In groups A–D, the cell viability on the 14th day was lower than that on the 7th day. In groups E and F,
S1P signiﬁcantly reduced cell viability. In group A and control group, cell activity cultured in DMEM was higher than that cultured in CMCM. The data were
expressed as mean ± SD (n = 3). Asterisk indicates statistically signiﬁcant (p< 0.05) difference of cell activity compared with CMCM group. Number sign in-
dicates statistically signiﬁcant (p< 0.05) difference of cell activity compared with 5-azacytidine group
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Effect of S1P on calcium transient
Figure 9 shows the electrophysiological features of the cells
from the four groups including group A (CMCM), group C
(CMCM+0.5μM S1P), group E (5-azacytidine) and group
F (5-azacytidine + 0.5μM S1P). The results showed that
the calcium transient happened only in the cells from group
C, while the phenomenon could not be observed in other
groups (data were shown in Figures S2 and S3 of
Supporting Information).
DISCUSSION
MSCs are considered as sources of seed cells in tissue engi-
neering, as they can be obtained from a wide variety of tis-
sues, including bone marrow, adipose tissue, cord blood,
placenta and peripheral blood.19–21 Recent studies have
shown that umbilical cord and adipose tissue are two most
attractive sources of MSCs22–24 as they are easy to obtain.
This would change the current situation of treating them as
medical wastes. A further beneﬁt is that their future applica-
tions are not subject to strict ethical complications. Similar
to MSCs from other sources, hUCMSCs and hATMSCs
have the potential to differentiate into adipocytes, osteo-
cytes, hepatocytes, ﬁbroblasts and endothelial cells.23,25–28
In addition, hUCMSCs and hATMSCs can also differentiate
into cardiomyocytes by treating them with 5-azacytidine or
maintaining them in CMCM.6,7,29,30 In these studies, MSCs
from the two sources were induced to differentiate into
cardiomyocytes and expressed cardiac speciﬁc markers after
2 to 5weeks, including sarcomeric α-actinin, cardiac tropo-
nin I, β-myosin heavy chain and connexin-43. These cardiac
speciﬁc markers enabled biological immunostaining as a
powerful tool to investigate the role of the differentiations
of hUCMSCs and hATMSCs into cardiomyocytes. We ob-
served that hUCMSCs and hATMSCs consistently began
to differentiate into cardiomyocytes and express cardiac spe-
ciﬁc markers around the 7th day of culturing. Our data
showed that hUCMSCs and hATMSCs, whether treated
with 5-azacytidine or cultured with CMCM, began to differ-
entiate into cardiomyocytes around 7 days of induction
rather than widely reported longer time induction (from 2
to 5weeks), an observation broadly consistent with previous
work as reported by Zhao et al.17 Furthermore, our work re-
ported here also showed that the expressions of the three
cardiac speciﬁc proteins at the 7th day were much weaker
than those on the 14th or 28th days. This observation alone
suggests that expressions of these speciﬁc proteins marking
the extents of differentiations of hUCMSCs and hATMSCs
into cardiomyocytes would need more than 2weeks.
S1P has been shown to play a critical role in the regula-
tion of numerous cardiovascular processes including angio-
genesis, cardiac function, vascular development and cardiac
development.31–33 In addition, a large number of studies
have shown that S1P plays a key role in a number of
fundamental biological processes including cell growth
and survival, regulation of cell migration and differentia-
tion.14,15,34 It is also implicated in the regulation of myo-
genic differentiation.35,36 A recent study has suggested that
S1P is able to maintain the multipotency of human adult
bone marrow and adipose tissue-derived stem cells.37 On
the basis of these ﬁndings, we hypothesized that S1P might
play roles in the differentiation of MSCs towards
caridiomyocytes. In this study, we have not only conﬁrmed
that S1P promoted the differentiations of hUCMSCs or
hATMSCs into functional cardiomyocytes when cultured
in CMCM but also found that S1P could enhance the differ-
entiations of hUCMSCs or hATMSCs into cardiomyocytes
when induced with 5-azacytidine. In addition, we found that
the inﬂuence of S1P was concentration dependent, which
was broadly in line with the report that S1P dose-
dependently stimulated the differentiation of hATMSCs to-
wards smooth muscle cells.13 More importantly, we found
that the differentiations were enhanced while cell activities
decreased with S1P concentration increasing. There should
thus be an optimal S1P concentration. On the basis of our
data, we consider that 0.5μM of S1P is the suitable concen-
tration for the induction of hUCMSCs or hATMSCs to dif-
ferentiate into cardiomyocytes.
This study has further demonstrated that S1P (in CMCM
groups) not only induced expressions of characteristic pro-
teins of cardiomyocytes but also gave rise to the calcium
transients, one of the most important speciﬁc electrophysio-
logical properties that rendered these cells capable of
Figure 9. Calcium transient detections of differentiated cells in different groups. The electrophysiological features of the cells were assayed including group A
(CMCM), group C (CMCM+ 0.5 μM S1P), group E (5-azacytidine) and group F (5-azacytidine + 0.5 μMS1P). The results showed that calcium transients were
observed only in hUCMSCs (A) or hATMSCs (B) in group C, while other groups did not express calcium transient (the data were shown in the Supporting
Information)
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functioning in vivo as cardiomyocytes. On the other hand,
no speciﬁc electrophysiological properties were observed
in the 5-azacytidine groups. This difference could be be-
cause of the cellular stimuli (e.g. transforming growth
factor-beta, TGF-β) that may be contained in CMCM but
not in 5-azacytidine induction medium. S1P may stimulate
MSCs to differentiate into functional cardiomyocytes by
working synergistically with cellular factors (TGF-β).38,39
Until now, the mechanism of S1P on the cardiomyogenic
differentiation of hUCMSCs or hATMSCs remains unclear.
Several researchers have suggested that S1P inﬂuenced nu-
merous physiological processes by coupling with G protein
receptor family in the membrane.15,40,41 Wamhoff et al.
demonstrated that S1P affected cell proliferation by regulat-
ing S1P1 and S1P3 receptors on cell surface.
42 Additionally,
S1P was found to play an important role in the differentia-
tion of smooth muscle by S1P2 because its action was re-
quired in the expression of α-actin.43 In another study,
S1P2 and S1P3 were found to be involved in the differentiat-
ing action of S1P towards smooth muscle of progenitor me-
sodermal cells.44 Nincheri et al.13 showed that hATMSCs
could bear ﬁve different S1P receptors. And in these recep-
tors, S1P2 was demonstrated to be, by pharmacological inhi-
bition, the most important for transmitting the myogenic
signal brought about by S1P, with a secondary role played
by S1P3. Nevertheless, the exact mechanism of S1P work-
ing synergistically with cellular stimuli to affect the
cardiomyogenic differentiation of hATMSCs or hUCMSCs
deserves to be further investigated.
CONCLUSIONS
From the consideration of expressions of the three cardiac
speciﬁc proteins (α-actin, connexin-43 and MYH-6) alone,
culturing in both CMCM and 5-azacytidine media would
sufﬁce in spite of variations in protein amount. S1P cannot
only promote differentiations of hUCMSCs or hATMSCs
into functional cardiaomyocytes when cultured in CMCM
but also enhance their differentiations towards
cardiomyocytes when working together with 5-azacytidine.
However, the beneﬁt of addition of S1P with 5-azacytidine
varied. In CMCM, differentiations were enhanced with
S1P concentration increasing, but cell activities declined.
The suitable differentiation time was found to be around
14 days, and the optimal concentration of S1P was 0.5μM
in media. S1P in CMCM can also generate the calcium tran-
sients from the induced cardiomyocytes. Calcium transient
is one of the most important speciﬁc electrophysiological
properties for these cells to function in vivo, and the combi-
nations of culturing conditions seemed to suggest that some
optimal conditions might exist for promoting them to occur.
Further work will be needed to establish these conditions.
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